DRUG · Mapped RxNorm record
Alprostadil
Normalized identity: alprostadilView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure
NCT00610051
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
End Stage Cardiac Failureunresolved
NYHF Class III-IVunresolved
Interventions
AlprostadilDRUG · verified · RxNorm: alprostadil
Sponsors & collaborators
Biopeutics Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00610051 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.